Chemotherapy fails in the absence of the purinergic receptor in breast and colon cancer [17], but loss-of-function alleles in P2X7 do not affect overall survival in NSCLC patients, irrespective of the administration and type of chemotherapy [18]. The gene discussed is P2RX7; the disease is colonic neoplasm.